Allied Market Research


Methadone Market

Methadone Market Size, Share, Competitive Landscape and Trend Analysis Report by Mode of Administration and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Methadone is an opioid medication utilized for the treatment of pain and as maintenance therapy. The medication helps to reduce cravings and withdrawal symptoms in people with opioid addiction. In addition, it helps to block the high sensation in parts of the brain and spinal cord that are caused by using opiates. Methadone helps to manage additions in patient dependent to heroin, morphine, or prescription painkillers. It can be used for a short or long duration depending on the requirement of the patient.

Rise in the number of people addicted to various opioid such as heroin and morphine is a major driving factor of the market. Moreover, increase in awareness towards the use of this medication and rise in number of people seeking help to detox boost the market growth. In addition, as the medication can be used for pain management, rise in the number of people with chronic pain is expected to increase the demand for methadone. However, the side effects associated with the use of methadone restrain the market growth.

The global methadone market is segmented based on mode of administration, application, and geography. Based on mode of administration, the market is classified into oral medicine and injections. Oral medicine is further bifurcated into tablets and liquid. Based on application, the market is categorized into operation, detoxification, and other. Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Qinghai Pharm, Roxane (Boehringer Ingelheim), CentralPharm, Mallinckrodt, Macfarlan Smith, VistaPharm, Diskets, Methadoes, Aurolife Pharma LLC, and Dolophine are provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
  • This report entails the detailed quantitative analysis of the current market and estimations which assists to identify the prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential¬†in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
  • An in-depth analysis of current research and clinical developments within market is provided with key market dynamic factors that helps understand the behavior of the market

Methadone Market Report Highlights

Aspects Details
By Mode of Administration
  • Oral Medicine
    • Tablets
    • Liquid
  • Injections
By Application
  • Operation
  • Detoxification
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Roxane (Boehringer Ingelheim), Macfarlan Smith, Dolophine, Aurolife Pharma LLC, Methadoes, VistaPharm, Qinghai Pharm, CentralPharm, Diskets, Mallinckrodt

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Methadone Market

Global Opportunity Analysis and Industry Forecast, 2023-2032